Will Mounjaro Affect Pregnancy — and What Should You Do?

Step 1: understand why Mounjaro and pregnancy don't mix

The short answer is that nobody knows what tirzepatide does to a developing pregnancy in humans, and that uncertainty is precisely why it is not suitable. Animal studies carried out during the drug's development showed some effects on foetal development at doses well above those used clinically, but animal data rarely translate directly to humans. The honest position, reflected in the NHS patient information for tirzepatide, is that there simply isn't enough evidence to call it safe. Regulators don't need proof of harm to recommend against use; the absence of safety data is sufficient.

One misconception worth gently setting aside: some people assume that because Mounjaro works on hormones and appetite (rather than being a traditional drug like an antibiotic) it must be relatively harmless in early pregnancy. That's not how drug safety assessment works. GLP-1 and GIP receptors are present in developing tissue, and the effects of activating them during gestation are not yet understood. Uncertainty is the concern, not a catalogue of known harms.

If you became pregnant while taking Mounjaro, stop the medicine and contact your midwife, GP or maternity team. They may also ask you to report the pregnancy to a specialist medicines in pregnancy register, your prescriber can advise on this. You can read more about the broader picture of Mounjaro and pregnancy on a dedicated page.

Step 2: know what to do about contraception while on treatment

This step matters more than many people realise. Mounjaro slows gastric emptying, which means oral contraceptive pills may be absorbed differently in the first weeks of treatment and after each dose increase. NHS England's guidance on weight-management injections advises women using the oral contraceptive pill to add a non-oral method (condoms, for instance) during the first four weeks of starting Mounjaro and for four weeks after every dose step up. This isn't a theoretical concern raised by lawyers; it's a practical instruction based on how the medicine works.

No equivalent absorption warning exists for semaglutide at present, which is one of several clinically meaningful differences between the two treatments. If you're currently on oral contraception and starting or titrating Mounjaro, raise this with your prescriber before your next dose change. If you have questions about how alcohol or other substances interact with tirzepatide alongside contraception concerns, the page on Mounjaro and alcohol covers that territory separately.

Women on HRT may also want to discuss moving to a transdermal formulation (patch or gel) with their doctor while taking Mounjaro, for the same gastric-emptying reason.

Step 3: plan your stop, and what comes after

If pregnancy is something you're planning for in the near future, the conversation with your prescriber should happen sooner rather than later. How far ahead of conception treatment should stop isn't a single fixed answer, it depends on your dose, your health, and your prescriber's assessment of your situation. What is consistent across guidance is that stopping should be planned, not rushed at a positive test.

Weight management after stopping treatment is a legitimate concern. Many people experience some weight regain when GLP-1 medicines are discontinued; your prescriber can help you think about lifestyle strategies to carry forward. There is also a growing body of clinical interest in what happens to metabolic health, including conditions like PCOS, when treatment ends, you can find more on that at Mounjaro, PCOS and pregnancy.

After delivery and once breastfeeding is complete, returning to treatment is something you can discuss with a prescriber. The page on Mounjaro after pregnancy covers re-starting and what a clinical review would involve at that point. If you'd like to understand the full effect of Mounjaro on pregnancy from a clinical perspective, that resource goes deeper on the evidence.

Step 4: talk to the right people

Your GP is always the first call if you discover a pregnancy unexpectedly. If you're already a patient at a private clinic or service, contact them the same day too, your prescriber needs to know, and your prescription must stop. The MHRA's Yellow Card scheme also accepts reports of suspected side effects during pregnancy, and the information helps build the evidence base for future guidance. You don't need to be a clinician to file a report.

If you're not yet pregnant but weighing up when to start Mounjaro relative to your family plans, a clinical consultation is the right starting point. Our prescribers at the nume clinical team review each case individually, they'll ask about your reproductive plans as part of the assessment, not as an afterthought. The full clinical breakdown of how Mounjaro may affect pregnancy covers the mechanism in more detail if you want to read further before booking. Whenever you're ready, you can start your free consultation and speak to our prescribers directly.